Inhibitory Role of Pentraxin-3 in Esophageal Squamous Cell Carcinoma

被引:8
|
作者
Ma, Dan [1 ,2 ,3 ,4 ]
Zong, Ye [1 ,2 ,3 ,4 ]
Zhu, Sheng-Tao [1 ,2 ,3 ,4 ]
Wang, Yong-Jun [1 ,2 ,3 ,4 ]
Li, Peng [1 ,2 ,3 ,4 ]
Zhang, Shu-Tian [1 ,2 ,3 ,4 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, 95 Yong An Rd, Beijing 100050, Peoples R China
[2] Natl Clin Res Ctr Digest Dis, Beijing 100050, Peoples R China
[3] Beijing Digest Dis Ctr, Beijing 100050, Peoples R China
[4] Beijing Key Lab Precanc Les Digest Dis, Beijing 100050, Peoples R China
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
Apoptosis; Esophageal Squamous Cell Carcinoma; Pentraxin-3; Proliferation; C-REACTIVE PROTEIN; BREAST-CANCER; PTX3; INFLAMMATION; FAMILY; MEMBER; IMMUNITY; CLONING;
D O I
10.4103/0366-6999.189921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Esophageal cancer is the sixth leading cause of cancer-related death worldwide. Pentraxin-3 (PTX3) is a member of the PTX superfamily. Here, we investigated the role of PTX3 in esophageal squamous cell carcinoma (ESCC). Methods: The effect of PTX3 on ESCC cell proliferation, colony formation, apoptosis, migration, and invasion was investigated using cell viability assays, colony formation assays, flow cytometry, and migration and invasion assays. The effect of PTX3 on the tumorigenicity of ESCC in vivo was investigated with xenograft studies in nude mice. Results: PTX3 overexpression in ESCC cells reduced cellular proliferation and colony formation (P 0.05) and increased the rate of apoptosis (P 0.05). PTX3 expression had no significant effect on the migratory or invasive potential of ESCC cells. In our mouse model of human ESCC, we achieved 100% successful tumor establishment. Compared with the control and empty vector-expressing groups, the PTX3-expressing group formed significantly smaller tumors (P 0.05). Conclusions: This study indicates that PTX3 might play an inhibitory role in ESCC.
引用
收藏
页码:2233 / 2240
页数:8
相关论文
共 50 条
  • [41] SIRT3 is a novel prognostic biomarker for esophageal squamous cell carcinoma
    Yan, Shu-Mei
    Han, Xian
    Han, Pei-Jin
    Chen, He-Mu
    Huang, Li-Yun
    Li, Yong
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [42] Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies
    Trojnar, Eszter
    Jozsi, Mihaly
    Szabo, Zsoka
    Reti, Marienn
    Farkas, Peter
    Kelen, Kata
    Reusz, George S.
    Szabo, Attila J.
    Garam, Nora
    Mikes, Balint
    Sinkovits, Gyorgy
    Mezo, Blanka
    Csuka, Dorottya
    Prohaszka, Zoltan
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [43] Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis
    Wu, Qian
    Guan, Shi-Yang
    Dan, Yi-Lin
    Zhao, Chan-Na
    Mao, Yan-Mei
    Liu, Li-Na
    Li, Xiao-Mei
    Wang, De-Guang
    Pan, Hai-Feng
    BIOMARKERS IN MEDICINE, 2019, 13 (16) : 1417 - 1427
  • [44] Insights into the Relationship between Pentraxin-3 and Cancer
    Bogdan, Maria
    Meca, Andreea-Daniela
    Turcu-Stiolica, Adina
    Oancea, Carmen Nicoleta
    Kostici, Roxana
    Surlin, Marin Valeriu
    Florescu, Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [45] Trafficking protein TMED3 promotes esophageal squamous cell carcinoma
    Yang, Yuxian
    Liu, Shiliang
    Xie, Chunxia
    Li, Qiaoqiao
    Gao, Tiantian
    Liu, Mengzhong
    Xi, Mian
    Zhao, Lei
    BIOMEDICAL JOURNAL, 2023, 46 (02)
  • [46] Preliminary study on the role and mechanism of KIRREL3 in the development of esophageal squamous cell carcinoma
    Yang, Bingbing
    Zhang, Xiane
    Zhou, Hao
    Zhang, Xiaoyan
    Yang, Wanjing
    Lu, Jing
    Guo, Zhiyu
    Dong, Ziming
    Wu, Qinghua
    Tian, Fang
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [47] FOXP3 expression in esophageal squamous cell carcinoma
    Wu, Shenghong
    Wang, Yu
    Xiao, Zhijun
    Zhang, Jinfeng
    He, Zhonghui
    Ye, Ming
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (11-12) : 331 - 339
  • [48] Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis
    Pereira, Jessica G.
    Silva, Telma Erotides
    Bansho, Emilia T. O.
    Morato, Edelton F.
    Pinheiro, Jose T.
    Muraro-Wildner, Leticia
    Bazzo, Maria Luiza
    Dantas-Correa, Esther Buzaglo
    Schiavon, Leonardo L.
    Narciso-Schiavon, Janaina L.
    ANNALS OF HEPATOLOGY, 2017, 16 (05) : 780 - 787
  • [49] Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer
    Liu, Chao
    Yao, Yao
    Wang, Wei
    MEDICAL ONCOLOGY, 2014, 31 (10) : 1 - 6
  • [50] Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma
    Wei, Hong
    Liu, Zhijun
    She, Hongyan
    Liu, Baoguo
    Gu, Junxia
    Wei, Dongmin
    Zhang, Xiangyang
    Wang, Jiufeng
    Qi, Shujing
    Ping, Fumin
    ONCOLOGY LETTERS, 2017, 13 (03) : 1866 - 1872